Evidence map›Paper›PMID 37740734›Full record

ArticleActa neuropathologica2023

Transcriptional mutagenesis of α-synuclein caused by DNA oxidation in Parkinson's disease pathogenesis.

Sambuddha Basu, Minkyung Song, Levi Adams, Inhye Jeong, Goun Je, Subhrangshu Guhathakurta, Jennifer Jiang, Nikpreet Boparai, Wei Dai, Fernando Cardozo-Pelaez and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Acta neuropathologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Sambuddha Basu *Burnett School of Biomedical Sciences, UCF College of Medicine, University of Central Florida, Orlando, FL, 32827, USA.
Minkyung Song *Department of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, 683 Hoes Lane West, Piscataway, NJ, 08854, USA.
Levi AdamsDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, 683 Hoes Lane West, Piscataway, NJ, 08854, USA.
Inhye JeongDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, 683 Hoes Lane West, Piscataway, NJ, 08854, USA.
Goun JeBurnett School of Biomedical Sciences, UCF College of Medicine, University of Central Florida, Orlando, FL, 32827, USA.
Subhrangshu GuhathakurtaBurnett School of Biomedical Sciences, UCF College of Medicine, University of Central Florida, Orlando, FL, 32827, USA.
Jennifer JiangDepartment of Cell Biology and Neuroscience, Institute for Quantitative Biomedicine, Rutgers University, Piscataway, NJ, 08854, USA.
Nikpreet BoparaiDepartment of Cell Biology and Neuroscience, Institute for Quantitative Biomedicine, Rutgers University, Piscataway, NJ, 08854, USA.
Wei DaiDepartment of Cell Biology and Neuroscience, Institute for Quantitative Biomedicine, Rutgers University, Piscataway, NJ, 08854, USA.
Fernando Cardozo-PelaezCenter for Environmental Health Sciences, University of Montana, Missoula, MT, 59812, USA.
Suren A TatulianDepartment of Physics, University of Central Florida, Orlando, FL, 32816, USA.
Kyu Young HanCREOL, The College of Optics and Photonics, University of Central Florida, Orlando, FL, USA.
Jordan ElliottDepartment of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, 08854, USA.
Jean BaumDepartment of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, 08854, USA.
Pamela J McLeanDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA.
Yoon-Seong KimDepartment of Neurology, Robert Wood Johnson Medical School, Institute for Neurological Therapeutics at Rutgers, Rutgers Biomedical and Health Sciences, 683 Hoes Lane West, Piscataway, NJ, 08854, USA. yk525@rutgers.edu.ORCID http://orcid.org/0000-0001-6246-5477
Rutgers, The State University of New Jersey · USUniversity of Central Florida · USMayo Clinic in Florida · USCenter for Environmental Health · US

Funding

Rutgers Helium Recovery System for High Field NMRR35GM136431 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI BAUM, JEAN S · 2020 to 2024
$3.3M
Contribution of transcriptional mutagenesis of oxidative DNA lesions to generatingnew mutant alpha-synuclein species and aggregation toward the pathogenesis of Parkinson'sdiseaseR01NS100919 · NINDS · UNIVERSITY OF CENTRAL FLORIDA · PI KIM, YOON-SEONG · 2018 to 2022
$1.7M
Pum2-dependent translational regulation of a-SYN near mitochondria and contribution to the pathogenesis of Parkinson's diseaseR01NS101461 · NINDS · UNIVERSITY OF CENTRAL FLORIDA · PI KIM, YOON-SEONG · 2018 to 2022
$1.7M
NIGMS NIH HHS R35 GM136431NIH HHS 1R01-NS100919NIH HHS 1R01-NS101461NIH HHS R35- GM136431NINDS NIH HHS R01 NS100919NINDS NIH HHS R01 NS101461
6 · The paper itself

Abstract

Oxidative stress plays an essential role in the development of Parkinson's disease (PD). 8-oxo-7,8-dihydroguanine (8-oxodG, oxidized guanine) is the most abundant oxidative stress-mediated DNA lesion. However, its contributing role in underlying PD pathogenesis remains unknown. In this study, we hypothesized that 8-oxodG can generate novel α-synuclein (α-SYN) mutants with altered pathologic aggregation through a phenomenon called transcriptional mutagenesis (TM). We observed a significantly higher accumulation of 8-oxodG in the midbrain genomic DNA from PD patients compared to age-matched controls, both globally and region specifically to α-SYN. In-silico analysis predicted that forty-three amino acid positions can contribute to TM-derived α-SYN mutation. Here, we report a significantly higher load of TM-derived α-SYN mutants from the midbrain of PD patients compared to controls using a sensitive PCR-based technique. We found a novel Serine42Tyrosine (S42Y) α-SYN as the most frequently detected TM mutant, which incidentally had the highest predicted aggregation score amongst all TM variants. Immunohistochemistry of midbrain sections from PD patients using a newly characterized antibody for S42Y identified S42Y-laden Lewy bodies (LB). We further demonstrated that the S42Y TM variant significantly accelerates WT α-SYN aggregation by cell and recombinant protein-based assays. Cryo-electron tomography revealed that S42Y exhibits considerable conformational heterogeneity compared to WT fibrils. Moreover, S42Y exhibited higher neurotoxicity compared to WT α-SYN as shown in mouse primary cortical cultures and AAV-mediated overexpression in the substantia nigra of C57BL/6 J mice. To our knowledge, this is the first report describing the possible contribution of TM-generated mutations of α-SYN to LB formation and PD pathogenesis.

Indexed as

Parkinson Disease8-Hydroxy-2'-Deoxyguanosinealpha-SynucleinAnimalsDNAHumansMiceMice, Inbred C57BLMutagenesis8-Hydroxy-2'-Deoxyguanosinealpha-SynucleinDNA8-oxodGAlpha-synuclein aggregationLewy bodiesParkinson’s diseaseTranscriptional mutagenesis

Identifiers

PMID37740734
PMCPMC10564827
OpenAlexW4386981697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.